Swedencare Ab · OMXSTO:SECARE
Swedencare Ab — Q2 2022 Earnings Presentation
15 slides from Swedencare Ab's earnings presentation, June 2022
Slide 1: Q2 Interim Report April–June 2022
Q2 INTERIM REPORT April – June 2022 Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Slide 2: Q2 2022 Highlights
Q2 2022 Highlights Strong sales with preparations for period of higher growth Sales record and solid demand despite world situation Organic growth 4% - 2022 target 20% Online excellent growth - continues Business development, integration and continued move from external to internal manufacturing Mar
Slide 3: Net sales and Op. EBITDA (MSEK)
Net sales (MSEK) Op.EBITDA (MSEK) 500 140 450 400 120 350 470,9 100 % 300 1 94 80 6% 14 25,2% 250 200 60 150 40 100 160,2 30,1% 20 50 0 - Q2 2021 Q2 2022 Q2 2021 Q2 2022
Slide 4: Key Performance Indicators Q2 2022
Key Performance Indicators Q2 2022
Slide 5: Sales per region Q2
Sales per region Q2 SWEDEN ASIA : 2% 3% 7% REST OF UK/RELAND REST OF THE WORLD gwepen 1% 1% 6% 21% REST OF EUROPE 9% EUROPE 11% NORTH AMERICA 62% — NORTH AMERICA. 2 SWEDENCARE
Slide 6: Sales per product category Q2
Sales per product category Q2
Slide 7: Sales per brand Q2
Sales per brand Q2 OTHER nutravet® 14% 3% Pet MD 11% PlaqueOff 7 12% Q2 2022 PRIVATE/CO LABEL 15% ily ‘ AV Naturvet 30% a FETS 7% 28 SWEDENCARE
Slide 8: Net Sales by region (MSEK) – North America
Net Sales by region (MSEK) North America • New focus and creation of a customer centric team for direct 400 connection with present and future veterinary customers 350 • Many group projects for optimization, production, other services and price negotiations for group not individual 300 companies and
Slide 9: Net Sales by region (MSEK) – Europe
Net Sales by region (MSEK) Europe • Solid quarter in most markets, Greece a bit more affected by 100 external factors but also there a pick-up in June 90 • France taken back distribution for pet retail, adding new 80 customers 70 78% • Innovet, strong profitability and grew stronger than market 60 •
Slide 10: Net Sales by region (MSEK) – Rest of the world
Net Sales by region (MSEK) Rest of the world 16 • Participated at InterZoo, Germany, the world’s biggest 14 Companion animal expo. Strong interest and many new 12 30% leads worked on at the moment • Strong sales in most external markets except China 10 • Especially Japan due to a very successful lau
Slide 11: Revenues and Adj. EBITDA
Revenues and Adj. EBITDA 500 119 140 450 120 400 95 350 100 300 80 250 48 57 60 200 48 150 37 40 100 20 50 - - Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Revenues Adjuste d EBITDA
Slide 12: Rolling 4 Quarters
Rolling 4 Quarters 1 300 |._.. 1 200 1 000 900 800 700 600 500 300 200 | WY ef Gr 100 rs i Te ee Qi Q2 Q3 @4 Ai Q2 @& A QI Q2 QA 24 A Q 2019 2020 2021 2022 MB Net Revenue ME ESITDA HE Operational EBITDA 2 SWEDENCARE
Slide 13: Priorities 2022
Priorities 2022 Use group size for increasing margin Increased marketing and sales efforts Brand and Product development Prioritizing efforts on strategic partners Organization & adding talent M&A opportunities
Slide 14: Q&A
Q&A 1. Related to the new deals that was indicated to be under negotiation, how are they progressing and is the market likely to be proactively informed about deal value over the contract period? 2. Are you holding the time plan for the Q3 production ramp-up at mainly Vetio but also NaturVet? 3. Wha
Slide 15: See you soon!
Live Chat starts in 5 min – See you soon!